Delivery Order SPE2DB22D1017-SPE2DB24FG2SV

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,245.30, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,457.72, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $7,149.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $26,258.28. The contract is for the supply of the pharmaceutical product RINVOQ ER 45 MG TABLET, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a $6,274.02 firm-fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a performance period ending on March 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568373757 ! RINVOQ ER 45 MG TABLET UU 28S, a medical supply product. The delivery order has a firm fixed price of $100,407.12 and a completion date of May 29, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,146,627 units of RINVOQ ER 15 MG TABLET, with a ceiling value of $7,965.19 and a performance period ending on May 6, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $6,506.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product "RINVOQ ER 30 MG TABLET UU 30S" and has an ultimate completion date of June 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $12,153.60, and a period of performance through June 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,128.87 firm fixed-price contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2SV
    Delivery Order

This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, is for the supply of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide.

The specific delivery order, valued at $7,068.48, is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. This contract has no set-aside designation and was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a firm fixed-price pricing type and an ultimate completion date of August 7, 2024.

Generated 11/5/24, 9:30 AM